Cellular fatty acid metabolism and cancer

E Currie, A Schulze, R Zechner, TC Walther, RV Farese - Cell metabolism, 2013 - cell.com
Cancer cells often have characteristic changes in metabolism. Cellular proliferation, a
common feature of all cancers, requires fatty acids for synthesis of membranes and signaling …

Liver X receptor biology and pharmacology: new pathways, challenges and opportunities

T Jakobsson, E Treuter, JÅ Gustafsson… - Trends in …, 2012 - cell.com
Nuclear receptors (NRs) are master regulators of transcriptional programs that integrate the
homeostatic control of almost all biological processes. Their direct mode of ligand regulation …

Saponins as modulators of nuclear receptors

T Zhang, S Zhong, T Li, J Zhang - Critical reviews in food science …, 2020 - Taylor & Francis
As plant-derived natural products, saponins have been widely applied for the dietary
modification of metabolic syndrome. However, the underlying mechanisms of their …

Targeting liver X receptors in cancer therapeutics

CY Lin, JÅ Gustafsson - Nature Reviews Cancer, 2015 - nature.com
Members of the nuclear receptor superfamily of ligand-dependent transcription factors carry
out vital cellular functions and are highly druggable therapeutic targets. Liver X receptors …

Broad anti-tumor activity of a small molecule that selectively targets the Warburg effect and lipogenesis

CA Flaveny, K Griffett, BEDM El-Gendy, M Kazantzis… - Cancer cell, 2015 - cell.com
Malignant cells exhibit aerobic glycolysis (the Warburg effect) and become dependent on de
novo lipogenesis, which sustains rapid proliferation and resistance to cellular stress. The …

Targeting nuclear receptors in neurodegeneration and neuroinflammation

S Willems, D Zaienne, D Merk - Journal of medicinal chemistry, 2021 - ACS Publications
Nuclear receptors, also known as ligand-activated transcription factors, regulate gene
expression upon ligand signals and present as attractive therapeutic targets especially in …

Dendrogenin A drives LXR to trigger lethal autophagy in cancers

G Segala, M David, P De Médina, MC Poirot… - Nature …, 2017 - nature.com
Dendrogenin A (DDA) is a newly discovered cholesterol metabolite with tumor suppressor
properties. Here, we explored its efficacy and mechanism of cell death in melanoma and …

Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk

LM Tai, S Mehra, V Shete, S Estus, GW Rebeck… - Molecular …, 2014 - Springer
The APOE4 allele of apolipoprotein E (apoE) is the greatest genetic risk factor for
Alzheimer's disease (AD) compared to APOE2 and APOE3. Amyloid-β (Aβ), particularly in a …

Ligands of therapeutic utility for the liver X receptors

R Komati, D Spadoni, S Zheng, J Sridhar, KE Riley… - Molecules, 2017 - mdpi.com
Liver X receptors (LXRs) have been increasingly recognized as a potential therapeutic
target to treat pathological conditions ranging from vascular and metabolic diseases …

[HTML][HTML] Remembering your A, B, C's: Alzheimer's disease and ABCA1

CT Lewandowski, MS Laham, GRJ Thatcher - Acta Pharmaceutica Sinica B, 2022 - Elsevier
The function of ATP binding cassette protein A1 (ABCA1) is central to cholesterol
mobilization. Reduced ABCA1 expression or activity is implicated in Alzheimer's disease …